1A5V | A:54-199 | ASV INTEGRASE CORE DOMAIN WITH HIV-1 INTEGRASE INHIBITOR Y3 AND MN CATION |
1A5W | A:54-199 | ASV INTEGRASE CORE DOMAIN WITH HIV-1 INTEGRASE INHIBITOR Y3 |
1A5X | A:54-199 | ASV INTEGRASE CORE DOMAIN WITH HIV-1 INTEGRASE INHIBITOR Y3 |
1VSD | A:54-199 | ASV INTEGRASE CORE DOMAIN WITH MG(II) COFACTOR AND HEPES LIGAND, HIGH MG CONCENTRATION FORM |
1VSE | A:54-199 | ASV INTEGRASE CORE DOMAIN WITH MG(II) COFACTOR AND HEPES LIGAND, LOW MG CONCENTRATION FORM |
1VSF | A:54-199 | ASV INTEGRASE CORE DOMAIN WITH MN(II) COFACTOR AND HEPES LIGAND, HIGH MG CONCENTRATION FORM |
1VSH | A:54-199 | ASV INTEGRASE CORE DOMAIN WITH ZN(II) COFACTORS |
1VSI | A:54-199 | ASV INTEGRASE CORE DOMAIN WITH CA(II) COFACTOR |
1VSJ | A:54-199 | ASV INTEGRASE CORE DOMAIN WITH CD(II) COFACTORS |
1VSL | A:54-199 | ASV INTEGRASE CORE DOMAIN D64N MUTATION WITH ZINC CATION |
1VSM | A:54-199 | ASV INTEGRASE CORE DOMAIN IN CITRATE BUFFER PH 5.0 |